行业

• 重置全部 ×
• 生命科学 ×
• 全球 ×

显示 81-89 个结果（共 89 个结果）

按受关注度排序 按好评度排序 按最新内容排序 按价格从低到高 按价格从高到低

• 

  Global Rare Disease Diagnostics Market 2021

  A rare disease, also referred to as an orphan disease, is any disease that affects a small percentage of the population. There are thousands of rare diseases. To date, six to seven thousand rare diseases have been discovered and new diseases are regularly described in medical literature. The global rare disease diagnostics market in terms of revenue is set to grow by US$ 12 亿期间 2021-2027, 以复合年增长率增长 (复合年增长率) 的 8.6% 在预测期内, 据数据和分析公司 StrategyHelix 称. Rising burden of diseases and increase in incidence and prevalence of genetic disorders and various types of cancer, increase in adoption of whole genome and exome sequencing, and increasing research funding and surge in usage for new techniques are driving market growth. 该报告对于活跃在该行业的公司和组织来说是宝贵的资源. It provides a cohesive picture of the rare disease diagnostics market to help drive informed decision making for industry executives, 政策制定者, 学术的, 和分析师.

  美元 2,750
• 

  Global Ophthalmic Devices Market 2021

  眼科设备是用于识别和治疗眼部缺陷或缺陷以及眼部疾病的医疗设备. 这些设备涵盖了多种设计类型，例如折射镜, 眼底照相机, 光学相干断层扫描系统, 周长, 裂隙灯, 和眼压计. The global ophthalmic devices market in terms of revenue is set to grow by US$ 9 亿期间 2021-2027, 以复合年增长率增长 (复合年增长率) 的 4.4% 在预测期内, 据数据和分析公司 StrategyHelix 称. 人口老龄化加剧, 疾病负担的增加以及眼科疾病发病率和患病率的增加正在推动市场增长. 该报告对于活跃在该行业的公司和组织来说是宝贵的资源. 它提供了眼科器械市场的整体图景，有助于推动行业高管做出明智的决策, 政策制定者, 学术的, 和分析师.

  美元 1,250
• 

  Global Asthma and COPD Devices Market 2021

  Asthma and COPD, including emphysema and chronic bronchitis are inflammatory diseases that cause airflow blockage and breathing-related problems. The global asthma and COPD devices market in terms of revenue is set to grow by US$ 2 亿期间 2021-2027, 以复合年增长率增长 (复合年增长率) 的 6.2% 在预测期内, 据数据和分析公司 StrategyHelix 称. North America held the highest share in the global asthma and copd devices market, while Asia Pacific is expected to grow at the highest CAGR during the forecast period. Increase in incidence and prevalence of asthma and COPD and growing geriatric population are driving market growth. 该报告对于活跃在该行业的公司和组织来说是宝贵的资源. It provides a cohesive picture of the asthma and COPD devices market to help drive informed decision making for industry executives, 政策制定者, 学术的, 和分析师.

  美元 2,250
• 

  Global CEP (Cerebral Embolic Protection) Systems Market 2021

  The global CEP (cerebral embolic protection) systems market in terms of revenue is set to grow by US$ 572 期间百万 2021-2027, 以复合年增长率增长 (复合年增长率) 的 27% 在预测期内, 据数据和分析公司 StrategyHelix 称. 该报告对于活跃在该行业的公司和组织来说是宝贵的资源. It provides a cohesive picture of the CEP (cerebral embolic protection) systems market to help drive informed decision making for industry executives, 政策制定者, 学术的, 和分析师.

  美元 450
• 

  Global Prostate Cancer Drug Market 2021

  The global prostate cancer drug market in terms of revenue is set to grow by US$ 11 亿期间 2021-2027, 以复合年增长率增长 (复合年增长率) 的 10.5% 在预测期内, 据数据和分析公司 StrategyHelix 称. 该报告对于活跃在该行业的公司和组织来说是宝贵的资源. It provides a cohesive picture of the prostate cancer drug market to help drive informed decision making for industry executives, 政策制定者, 学术的, 和分析师.

  美元 450
• 

  Global Biologics CDMO (Contract Development and Manufacturing Organization) 市场 2021

  The global biologics CDMO (contract development and manufacturing organization) market in terms of revenue is set to grow by US$ 22 亿期间 2021-2027, 以复合年增长率增长 (复合年增长率) 的 20.3% 在预测期内, 据数据和分析公司 StrategyHelix 称. 该报告对于活跃在该行业的公司和组织来说是宝贵的资源. It provides a cohesive picture of the biologics CDMO (contract development and manufacturing organization) 市场帮助行业高管做出明智的决策, 政策制定者, 学术的, 和分析师.

  美元 450
• 

  Global Heparin API Market 2021

  The global heparin API market in terms of revenue is set to grow by US$ 1 亿期间 2021-2027, 以复合年增长率增长 (复合年增长率) 的 6.5% 在预测期内, 据数据和分析公司 StrategyHelix 称. 该报告对于活跃在该行业的公司和组织来说是宝贵的资源. It provides a cohesive picture of the heparin API market to help drive informed decision making for industry executives, 政策制定者, 学术的, 和分析师.

  美元 450
• 

  Global Enoxaparin Finished Dose Market 2021

  The global enoxaparin finished dose market in terms of revenue is set to grow by US$ 1 亿期间 2021-2027, 以复合年增长率增长 (复合年增长率) 的 5.9% 在预测期内, 据数据和分析公司 StrategyHelix 称. 该报告对于活跃在该行业的公司和组织来说是宝贵的资源. It provides a cohesive picture of the enoxaparin finished dose market to help drive informed decision making for industry executives, 政策制定者, 学术的, 和分析师.

  美元 450
• 

  Global Heparin Finished Dose Market 2021

  The global heparin finished dose market in terms of revenue is set to grow by US$ 2 亿期间 2021-2027, 以复合年增长率增长 (复合年增长率) 的 5.3% 在预测期内, 据数据和分析公司 StrategyHelix 称. 该报告对于活跃在该行业的公司和组织来说是宝贵的资源. It provides a cohesive picture of the heparin finished dose market to help drive informed decision making for industry executives, 政策制定者, 学术的, 和分析师.

  美元 450